CSS LLC’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,341
| Closed | -$3.62K | – | 729 |
|
|
2022
Q4 | $3.62K | Hold |
1,341
| – | – | ﹤0.01% | 636 |
|
|
2022
Q3 | $5K | Sell |
1,341
-63
| -4% | -$235 | ﹤0.01% | 715 |
|
|
2022
Q2 | $10K | Hold |
1,404
| – | – | ﹤0.01% | 783 |
|
|
2022
Q1 | $16K | Hold |
1,404
| – | – | ﹤0.01% | 836 |
|
|
2021
Q4 | $26K | Hold |
1,404
| – | – | ﹤0.01% | 922 |
|
|
2021
Q3 | $35K | Hold |
1,404
| – | – | ﹤0.01% | 873 |
|
|
2021
Q2 | $89K | Hold |
1,404
| – | – | ﹤0.01% | 758 |
|
|
2021
Q1 | $173K | Sell |
1,404
-208
| -13% | -$25.6K | 0.01% | 619 |
|
|
2020
Q4 | $183K | Sell |
1,612
-139
| -8% | -$15.8K | 0.01% | 463 |
|
|
2020
Q3 | $209K | Hold |
1,751
| – | – | 0.01% | 352 |
|
|
2020
Q2 | $218K | Buy |
1,751
+1,127
| +181% | +$140K | 0.01% | 291 |
|
|
2020
Q1 | $120K | Buy |
+624
| New | +$120K | 0.01% | 312 |
|